Abstract
Serum specimens from patients attending sexually transmitted disease (STD) clinics in Denver and several southeastern US cities were tested for antibody to human T-lymphotropic virus type I or II (HTLV-I/II). In Denver, 8 (2.1%) of 384 patients with a history of intravenous (IV) drug use, versus none of 201 non-IV-drug users, were HTLV-I/II seropositive. Only 2 (0.18%) of 1095 STD clinic patients from the southeastern USA had antibodies to HTLV-I/II. These data document a low prevalence of HTLV-I/II in STD clinic patients from the southeastern USA and confirm that IV drug use is an important risk factor for HTLV-I/II in the USA.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 241-244 |
| Number of pages | 4 |
| Journal | Journal of Infectious Diseases |
| Volume | 162 |
| Issue number | 1 |
| State | Published - Jul 1990 |
| Externally published | Yes |
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Immunology
Fingerprint Dive into the research topics of 'Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA'. Together they form a unique fingerprint.
Cite this
Khabbaz, R. F., Douglas, J. M., Judson, F. N., Spiegel, R. A., St Louis, M. E., Whittington, W., Hartley, T. M., Lairmore, M. D., & Kaplan, J. E. (1990). Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA. Journal of Infectious Diseases, 162(1), 241-244.